Clinical Trials in the Era of Effective Therapies | Luca Richeldi, MD, PhD 

Participating in clinical trials is an important option for those living with pulmonary fibrosis (PF). But what do trials look like now that there are approved therapies for idiopathic pulmonary fibrosis (IPF)? Dr. Luca Richeldi, MD, PhD, presenting at the PFF Summit 2015: From Bench to Bedside, provides an overview of the fundamentals of clinical trial design and underlines the need for a patient-centered approach to trials.